Home » News » Novavax vaccine approved: – Norway has ordered 500,000 doses

Novavax vaccine approved: – Norway has ordered 500,000 doses

On Monday, the European Medicines Agency (EMA) gives the green light to the corona vaccine from the American drug manufacturer Novavax for people over 18 years of age.

The temporary approval also allows for the use of the vaccine in Norway.

Dagbladet is informed by State Secretary Ole Henrik Krat Bjørkholt (Labor Party) in The Ministry of Health and Care Services that Norway has ordered more than 500,000 doses.

It is up to the National Institute of Public Health to decide whether it should be used in the vaccination program.

– We do not yet know what role the vaccine from Novavax will have in the coronary vaccination program and which groups it may be relevant for. It will be considered in more detail when we know how many doses we will have access to and when the vaccine will be available in Norway, says FHI chief physician Sara Watle to Dagbladet.

– Good numbers

The Novavax vaccine is given in two doses, at least 21 days apart.

The company’s clinical trials, which has included a total of over 45,000 people, has shown an effect of around 90 percent against symptomatic covid-19 infection seven days after vaccination with the second dose.

The reported side effects are considered by the EMA to be mild or moderate, and should have passed within a few days.

The studies were performed during a period when the original coronavirus, in addition to the alpha and beta variants, was circulating.

– These are basically good numbers. Slightly below the mRNA vaccines, but above other vaccines. It will be very important to get data on whether it also protects against omicron, says medical director of the Norwegian Medicines Agency, Steinar Madsen, to Dagbladet.

There is currently little data on the vaccine’s effect against newer virus variants, including omicron. The company announced in late November that they are in the process of developing a new vaccine against the omicron variant.

VACCINE: Department director in FHI Line Violence with encouragement to the voluntarily unvaccinated. Host: Christian Fjermeros
view more

Traditional vaccine technology

The Novavax vaccine uses a traditional subunit technology – unlike the mRNA vaccines from Pfizer and Moderna.

Subunit vaccines do not contain whole viruses, only small pieces of it (subunits). The bites cannot in themselves cause disease, but stimulate the immune system to make antibodies against the virus.

This technology is also used in hepatitis B vaccine and in some flu vaccines.

Precisely for this reason, Sweden’s vaccine coordinator, Richard Bergström, believes that people who have been skeptical of the mRNA vaccines may be more interested in being vaccinated against it.

– There is a reason why we have taken in large volumes. I now work with the Public Health Authority (the Swedish National Institute of Public Health journ. Note) every day, and that is exactly it: It may be that someone would rather take this, says Bergström to Expressen.

When asked who the vaccine may be relevant for in this country, Steinar Madsen is more reluctant.

– It is currently too early to say anything about. There are gradually more vaccines and drugs against covid-19. One of the things that will be important in the future is to decide how they should be included in prevention and treatment.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.